Sino Biological Newly Launched A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)
via The Scientist RSS https://ift.tt/3pzhmFW Sino Biological, Inc. ( SHE: 301047) announced on Monday that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the Spike protein. https://ift.tt/eA8V8J December 08, 2021 at 11:45AM